4.6 Letter

COVID-19 associated coagulopathy: Thrombosis, hemorrhage and mortality rates with an escalated-dose thromboprophylaxis strategy

Journal

THROMBOSIS RESEARCH
Volume 196, Issue -, Pages 483-485

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.thromres.2020.10.004

Keywords

COVID; Thromboprophylaxis; Escalated-dose; Anticoagulation; VTE; Thromboembolism; Hemorrhage

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available